rs2037639

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BP7

This summary comes from the ClinGen Evidence Repository: The c.353-22C>T variant in PAH has a MAF of 0.7066 in the gnomAD East Asian population. This intronic variant does not have a predicted impact on splicing. In summary this variant meets criteria to be classified as benign. PAH-specific ACMG/AMP criteria applied: BA1, BP7 LINK:https://erepo.genome.network/evrepo/ui/classification/CA229520/MONDO:0009861/006

Frequency

Genomes: 𝑓 0.22 ( 4517 hom., cov: 31)
Exomes 𝑓: 0.25 ( 48672 hom. )

Consequence

PAH
NM_000277.3 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel B:8O:1

Conservation

PhyloP100: -0.216

Publications

12 publications found
Variant links:
Genes affected
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]
PAH Gene-Disease associations (from GenCC):
  • phenylketonuria
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
  • classic phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • maternal phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild hyperphenylalaninemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP7
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAHNM_000277.3 linkc.353-22C>T intron_variant Intron 3 of 12 ENST00000553106.6 NP_000268.1 P00439A0A024RBG4
PAHNM_001354304.2 linkc.353-22C>T intron_variant Intron 4 of 13 NP_001341233.1
PAHXM_017019370.2 linkc.353-22C>T intron_variant Intron 3 of 6 XP_016874859.1
LOC124902999XR_007063428.1 linkn.808-2307G>A intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAHENST00000553106.6 linkc.353-22C>T intron_variant Intron 3 of 12 1 NM_000277.3 ENSP00000448059.1 P00439

Frequencies

GnomAD3 genomes
AF:
0.221
AC:
33548
AN:
151976
Hom.:
4519
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.265
Gnomad AMR
AF:
0.190
Gnomad ASJ
AF:
0.277
Gnomad EAS
AF:
0.690
Gnomad SAS
AF:
0.335
Gnomad FIN
AF:
0.259
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.230
Gnomad OTH
AF:
0.233
GnomAD2 exomes
AF:
0.274
AC:
68767
AN:
250962
AF XY:
0.278
show subpopulations
Gnomad AFR exome
AF:
0.124
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.274
Gnomad EAS exome
AF:
0.707
Gnomad FIN exome
AF:
0.265
Gnomad NFE exome
AF:
0.237
Gnomad OTH exome
AF:
0.263
GnomAD4 exome
AF:
0.247
AC:
352222
AN:
1425802
Hom.:
48672
Cov.:
26
AF XY:
0.250
AC XY:
178113
AN XY:
711592
show subpopulations
African (AFR)
AF:
0.120
AC:
3930
AN:
32788
American (AMR)
AF:
0.189
AC:
8437
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.280
AC:
7244
AN:
25908
East Asian (EAS)
AF:
0.680
AC:
26906
AN:
39540
South Asian (SAS)
AF:
0.329
AC:
28180
AN:
85578
European-Finnish (FIN)
AF:
0.266
AC:
14203
AN:
53348
Middle Eastern (MID)
AF:
0.273
AC:
1556
AN:
5706
European-Non Finnish (NFE)
AF:
0.228
AC:
246332
AN:
1079078
Other (OTH)
AF:
0.261
AC:
15434
AN:
59196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
12561
25122
37682
50243
62804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8510
17020
25530
34040
42550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.221
AC:
33549
AN:
152092
Hom.:
4517
Cov.:
31
AF XY:
0.224
AC XY:
16679
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.129
AC:
5350
AN:
41518
American (AMR)
AF:
0.190
AC:
2907
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.277
AC:
962
AN:
3470
East Asian (EAS)
AF:
0.690
AC:
3556
AN:
5150
South Asian (SAS)
AF:
0.333
AC:
1603
AN:
4812
European-Finnish (FIN)
AF:
0.259
AC:
2740
AN:
10566
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.230
AC:
15615
AN:
67978
Other (OTH)
AF:
0.234
AC:
492
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1264
2528
3791
5055
6319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.214
Hom.:
5372
Bravo
AF:
0.214
Asia WGS
AF:
0.432
AC:
1504
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Phenylketonuria Benign:5
May 04, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 27, 2020
ClinGen PAH Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The c.353-22C>T variant in PAH has a MAF of 0.7066 in the gnomAD East Asian population. This intronic variant does not have a predicted impact on splicing. In summary this variant meets criteria to be classified as benign. PAH-specific ACMG/AMP criteria applied: BA1, BP7 -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:1
-
DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.1
DANN
Benign
0.60
PhyloP100
-0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2037639; hg19: chr12-103271350; API